Description:A.INVENTION TITLE

Multi-Dimensional Data Fusion Framework for AI-Driven Heart Disease Diagnosis Using Clinical, Lifestyle, and Genomic Features
B. PROBLEM STATEMENT:
Heart disease has been among the main causes of death in majority of regions in the world and thus imposing astronomical burden to the health care systems. The diagnostic methods available tend to be based on the single-dimensional nature of data, e.g., on the clinical tests (e.g., blood pressure, cholesterol levels, ECG results). These clinical markers are useful, but they cannot describe the interplay of the dozens of factors that interact in an intricate way and involve lifestyle behaviors (diet, physical activity, smoking, alcohol, and stress), and genetic predispositions (DNA variants and inherited conditions), which are all risk factors in cardiovascular disease. Consequently, the doctors and diagnostic methods are forced to commonly confront three critical issues:
• Fragmented Diagnosis: The method of clinical-only ignores the effects of lifestyle and genetic factors that may lead to the patients with high-risk group being diagnosed or over-diagnosing the patients with low-risk group.
• Weak Predictive Accuracy: The existing systems cannot be viewed as extremely accurate in terms of early detection, thereby resulting in the follow-up interventions and ineffective outcomes without the multi-dimensional approach to the information.
• Data Silos and Underutilization: Health data sets of medical records, genetic testing, and wearable/lifestyle tracking data are very big and are not combined into one to be analyzed as a whole (data silos). This will result in poor wasteful health knowledge.
Moreover, most of the existing machine learning or artificial intelligence (AI) diagnostic systems are focused, as most have been applied on small and domain-specific datasets and cannot be generalized to other populations. These limitations hamper their practice in the real clinical settings.
The problem is more complicated in resource limited and rural medical facilities whereby there is a lack of a high level of diagnostic knowledge. A system with close and effective and automated functionality involving the incorporation of clinical, lifestyle, and genetic data into a single diagnostic pipeline would make it possible to provide earlier diagnosis, better diagnosis, and enhanced treatment planning of the heart disease among the diverse populations.

C. EXISTING SOLUTIONS
Conventionally, diagnosis of heart disease is entirely based on the clinical parameters of blood pressure, level of cholesterol, electrocardiogram (ECG) and echocardiography. Although such tests are required in giving important information related to the well-being of the cardiovascular system, they are unidimensional tests that might not give the full image of the risk factors. To demonstrate a point, two patients can have exactly the same results of clinical tests but they can share a radically different health results because of having been exposed to different lifestyle behaviors or genetic predispositions. Therefore, as effective as first-line diagnostics, clinical-only solutions are inferior to the effect of having an overall or personal examination of heart disease.
It already has systems that are aimed at taking lifestyle factors into consideration when predicting the risk (diet, exercise, smoking, and alcohol) into risk prediction. There are some like the Framingham Risk Score and the like population based tools of assessment. However, these models are founded on statistical relations and average values; rather than accuracy at an individual level. Their explanatory capacity is limited because they are not adequate to explain interactions among risk factors between lifestyle and genetic predispositions. This will in turn cause the misclassification of lifestyle-based models where the heterogeneous population with different cultural and behavioral patterns is involved.
Genomics have led to the increased availability of genetic testing of cardiovascular risk. There are also commercially available genetic tests that can identify mutations or variants that can be attributed to heart disease including familial hypercholesterolemia. Despite these solutions providing good predictive information, they are often restricted by their high cost, laboratory specialization and the inability to use dynamic variables such as lifestyle change or changing clinical information. This is not extensive enough hence they are ineffective as one diagnostic test.
The past few years have been linked to developing AI-based models that forecast heart diseases, utilize machine learning, and deep learning. These models often relate the medical imaging variables (e.g., the chest X-rays, CT scans, or echocardiograms) or organized clinical records to estimate the risk of the disease. The AI methods have an advantage over the classical statistical methods, they tend to be more precise than the latter, and they are frequently small-data limited, application-specific, and not generalized into other populations. Moreover, the majority of AI systems are black-box and do not offer clinicians sufficient interpretability, which reduces the level of clinical trust and adoption.
Overall, offered solutions whether it is a clinical testing, lifestyle models, genetic test, or AI tools are single-sided and incomplete. They fail to integrate clinical, lifestyle and genetic data into a single type of diagnosis hence they lack the opportunity to give holistic and accurate diagnosis. In addition, the majority of the available solutions are not designed to operate in real time in different settings especially in resource limited regions whereby cardiovascular diseases are overburdened. This leads to an immediate need of the multi-dimensional integration, explainable, and accessible data system that can be utilized successfully in heart disease diagnosis.

D. Abstract with keywords
The invention is a multi-dimensional data fusion model used to diagnose heart diseases in a robust manner based on the combination of the clinical parameters, behaviors associated with lifestyles and genetic data into a single artificial intelligence (AI) system. Contrary to other traditional diagnostic methods that use standalone datasets, the proposed model uses the state-of-the-art deep learning models, feature blending approaches, and explainable AI to improve accuracy, generalization, and transparency. The framework allows us to identify the risks early, risk stratification, and personalized treatment planning with the flexibility to apply it in real-time, both in a clinical setting and in a mobile setting. This solution will deal with the shortcomings of fractured diagnostics and create a scalable, dependable, and interpretable platform to healthcare practitioners, researchers, and patients.

Keywords: Heart disease diagnosis, multi-dimensional data fusion, clinical lifestyle and genetic integration, deep learning, explainable AI

E. Preamble
The invention is associated with the artificial intelligence framework of heart disease diagnosis through the incorporation of multi dimensional health data such as clinical data, lifestyle data, and genetic data. The system uses deep learning models of data fusion and explainable AI to deliver high accuracy, reliability, and interpretable diagnostic results. The invention focuses on the real-time applicability problem in clinical settings, mobile settings, and telehealth and overcomes the limitations of the currently fragmented solutions and creates an all-encompassing platform in early detection and personalized healthcare.

F.Methodology
The proposed concept presents a multi-dimensional design of data fusion that incorporates clinical, lifestyle, and genetic data to provide a valid and reasonable diagnosis of heart disease. The methodology comes up with a series of procedures that identify nonhomogeneous data preprocessing, harmonization and analysis into an integrated deep learning framework.

Step 1 Data Collection and Preprocessing
Three general categories of patient data, including clinical, lifestyle, and genetics are the beginning of this system. The clinical data would be those indicators that can be quantified, like the blood pressure and cholesterol among others, the electro cardiogram (ECG) level and echocardiography. Habits are lifestyle characteristics of the patients including eating habits, physical activities, smoking, alcohol, sleeping and stress. The genetic information consists of DNA variants, biomarkers and family history predictors of cardiovascular risk. The preprocessing of the raw data (normalization, missing values, use of categorical codes, scaling of features) is done to make sure that it is compatible with all these different sources. This ensures that all the inputs are of the same format with which deep learning models can be used.

Step 2: Feature Extraction
After the preprocessing stage, any form of data is presented to distinct neural encoders that aim at producing discriminatory features. The numerical and structured clinical data is sent through a multilayer perceptron (MLP) or one-dimensional CNN so as to reveal the medical patterns of the data. Recurrent networks (LSTM) Lifestyle Data are recurrent, and temporal and this data is analyzed using recurrent networks (LSTM) networks. The complex genetic data is translated with the help of CNNs and attention systems that identify the critical genomic markers with the help of the highly sophisticated genetic data. The parallel feature extraction process also makes sure that all the dimensions of data were represented to the system and it is significant.

Step 3: Data Fusion Layer
The features derived out of clinical, lifestyle and genetic encoders are fused together in a fusion layer. It is acquired with the help of concatenation and attention-based operations that define the relations in the datasets. The salient and irrelevant noise are accentuated and deemphasized respectively with the help of Squeeze and Excitation (SE) block. This multi-level integration approach allows the system to elaborate on complex association which consists of the potential impact of lifestyle choices to make genetic disposition more extreme or the potential impact of clinical conditions to correlate with genetic and behavior variables.

Step 4: Classification Layer
The description of features is overall submitted to classification module. This is claimed to average pool on the global world to reduce the dimensionality and follow up density of fully connected layers to encapsulate knowledge that is discovered. The final division is achieved with the help of the Softmax layer that makes a binary decision of whether a patient was under a threat of heart disease or not. Such a classification approach ensures that there is a feeling of efficiency of calculating and diagnostic power.

Step 5: Visualization
The system uses the Grad-CAM (Gradient weighted Class Activation Mapping) to address the issue of deep learning as a black box framework. The process creates heatmaps that unleash the elements and data volume of elements that influence the final decision. Researchers and medical practitioners will have a chance to observe how the prediction has been made that will lead to increased trust and reliability and uptake of the system by the medical practitioners and the researchers.

Step 6: Deployment
The created model is then trained and scaled to the actual world and implemented on the majority of different platforms. It can be utilized by the hospitals as part of the electronic health records (EHR) systems to help physicians in their diagnosis. This could be essential to engage the model on cloud computing whereby there is a colossal screening program being conducted in a health climate. To make it on demand, a smaller edition is developed that may be used in mobile applications, wearable where real time surveying and decision support is required even in the rural and resource constrained area. This can ensure that the system is so accurate yet solutions to a tremendous number of healthcare settings which are scaled and workable exist.

A flow chart view of the proposed methodology is shown below:

Figure 1. Flow diagram of Methodology
Figure 1 was used to show the general structure of the proposed multi-dimensional data fusion system used to diagnose heart diseases. The system is set to manage heterogeneous sources of data by harmonizing them into a single diagnostic pipeline, which is precise, interpretable and implementable in the real-time healthcare contexts.
The data collection module is the first stage of the workflow that collects three different categories of data the clinical data (measures of blood pressure, cholesterol, ECG and echocardiogram levels), the lifestyle data (diet, exercise frequency, smoking habits, alcohol use, sleep quality and stress levels), and the genetic data (measures of DNA variants, family history and genetic biomarkers related to a risk of cardiovascular disease). Such inputs are preprocessed with normalization, treatment of missing values, encoding categorical variables, and standardization, which are tasks that are used to maintain uniformity across the various data modalities.
Conventionally, diagnosis of heart disease is entirely based on the clinical parameters of blood pressure, level of cholesterol, electrocardiogram (ECG) and echocardiography. Although such tests are required in giving important information related to the well-being of the cardiovascular system, they are unidimensional tests that might not give the full image of the risk factors. To demonstrate a point, two patients can have exactly the same results of clinical tests but they can share a radically different health results because of having been exposed to different lifestyle behaviors or genetic predispositions. Therefore, as effective as first-line diagnostics, clinical-only solutions are inferior to the effect of having an overall or personal examination of heart disease..
The resulting fused representation is then fed through the classification layer, composed of global average pooling, fully connected dense layers and a Softmax function which gives a binary answer: does the patient have a risk of heart disease or not. The architecture also supports the use of Grad-CAM (Gradient-weighted Class Activation Mapping) to make heatmaps of the important elements and the decision-making paths of the model, making the architecture more interpretable. This readability increases usability and trustworthiness among the medical practitioners.
Lastly, the architecture is multi-platform supportable. The trained model can be incorporated into the hospital information systems to support clinical decision-making, deployed on a large scale on cloud platforms to support screening large populations, or be deployed on the light-weight versions on mobile and wearable devices to support real-time monitoring in remote or resource-constrained settings. Therefore, the system will be more accurate, explainable, and accessible to overcome the weaknesses of the current siloed systems of diagnostics. .

G. Result

It was compared to other state-of-the-art deep learning models, such as ResNet and InceptionV4, VGG, MobileNet and combination Inception + ResNet, and tested on the proposed multi-dimensional data fusion framework. The assessment was based on the classification accuracy in various testing (Conditions 1, Condition 100, and Condition X), and the intent was to test how well diagnostic reliability would be measured under different real-life conditioning.

Model Accuracy Comparison
As illustrated in figure 2, the performance of the models can be presented. Condition 1 InceptionV4 performed best followed by the hybrid Inception + ResNet model and lastly VGG, which was the lowest performer. It is notable that Conditions in ResNet had a lot of variation with a much higher accuracy in Condition X as compared to Condition 1. This observation indicates that CNN-based models are sensitive to contextual-based factors such as light, input and noise resolution.

Table 1: Best Results Obtained Across Conditions
Model Accuracy (%) Condition
ResNet 70 Condition 1
InceptionV4 85 Condition 100
VGG 80 Condition 100
MobileNet 75 Condition 1
Inception + ResNet 85 Condition X

Figure 2. Model Accuracy obtained
Significant observation: Inception V4 and inception + ResNet scored the greatest accuracy (85) under different circumstances of testing, which implies that hybridization methods offer strong results.

Correlation Analysis
Figure 3 depicts a heatmap of the correlation of the model performances across different scenarios. The outcome of the analysis shows that hybrid models are more consistent and stronger with the ground-truth labels compared to the standalone CNN models. It means that there is an improvement in data fusion and integration of architecture, which leads to more generalization and minimization of influence on condition-related variations.

Figure 3: Correlation Heatmap of Model Performance

The correlation heatmap of model performances under various testing conditions as shown in figure 3 reveals the inter-relationships between ResNet, InceptionV4, VGG and MobileNet as well as the hybrid Inception + ResNet model. The diagonal values are the ones that are perfectly correlated to self (1.0), whereas the off-diagonal values are the ones that are correlated to a certain extent that predicts behavior. Interestingly, the hybrid model is the most correlated with all other models (0.84) and it can be considered to be stable and applicable to different situations. Correlations are also high with inceptionV4 especially with the hybrid model (0.90) which proves their excellent and stable performance. Comparatively, ResNet and VGG exhibit weaker values, implying that their predictions in different conditions are more varied. Through this analysis, the power of hybrid architectures in heart disease diagnosis can be highlighted.

Explainability through Grad-CAM.
The interpretation of predictions by grad-CAM was stimulated (Figure 4). These heat maps show the specific details and dimensions of data (e.g. ECG signals, genetic markers, lifestyle variations) which made a difference in classification. The results confirm that the model is not noise-oriented but medically important attributes are dealt with and make it more trusted and usable by the clinicians.

Figure 4: a) Original Input Image, b) Grad-CAM Visualization
The diagram below (Fig. 4) demonstrates the use of Grad-CAM (Gradient-weighted Class Activation Mapping) to the suggested heart disease diagnostics model. The heatmaps placed on top of the original image show the most important areas of the input data that led to the decision of the classification in the form of heatmaps. These interpretability capabilities allow clinicians and researchers to know what characteristics were involved in the outcome, including the presence of certain clinical features, genetic characteristics, or lifestyle factors. Grad-CAM promotes trust and acceptance of the system in sensitive healthcare settings by providing a clear decision pathway, which at the same time ensures that predictions are reliable.

Deployment Results
Figure 5 shows how the trained system will be deployed. The model when implemented on cloud servers and hospital systems enabled real-time inference and latency of less than 200ms. Similar accuracy (82%) was obtained with the mobile-optimized variant with less computation needs, so it can be applied in rural settings and in resource-constrained settings.

Figure 5: Deployment Workflow

As Figure 5 shows, the prototypical system is planned to be connected with other platforms, which will be adopted in the real-time through the deployment of the trained AI model. The model can be deployed on the cloud servers to support large-scale screening, in the information systems of hospitals to support doctors with diagnoses, or on mobile and wearable devices to enable patients to be monitored on the patient side in a rural or resource-limited setting as shown in the workflow. All these deployment pathways are oriented towards the provision of real-time predictions, accessibility and scalability and practical impact across different healthcare environments.

Key Insights
The hybrid models will always perform better than the CNNs operating individually particularly in different situations.
• The aspect of data fusion assists to a significant degree in the sense of enhancing robustness as well as reducing the impact of performance that follows due to contextual variations.
• The predictions are interpretable, which is achieved with explainable AI (Grad-CAM) to increase confidence among practitioners.
• Applicability in the real life Mobile deployment feasibility is a way that bridges the gap between research and healthcare practice.
• The proposed system can be a scaleable AI-based cardiovascular-based diagnostic assistant.

H. Discussion
The innovation suggested is a multi-dimensional data fusion model that is the combination of the clinical, lifestyle, and the genetic data to give powerful and understandable diagnosis of heart diseases. This is the transformation that will be a colossal improvement of the current diagnostic systems that have been typified by silo operations by emphasizing on clinical, behavioural or genetic. The invention suggests the different streams of data to one diagnostic pipeline in this way, the complicated interaction of the risk determinants is contemplated resulting to a better level of accuracy, generalizability and clinical utility.
Its combative nature of deep learning, a mixture of the strengths of complemented models of ResNet, MobileNet, Inception, and VGG-16 is debatable as one of the strengths of the invention. Such multi-scaled feature extraction is also not used to be sensitive of the variation in the conditions of the original input like quality of image, the light condition and the noise caused by hierarchical pyramid based structure, residual block and inception block. In addition, its attention mechanism (Squeeze-and-Excitation blocks) can make the feature selection more interpretable and stronger, thus, the system can pay attention to the most important features and disregard irrelevant signals. This does not only work well in promoting the outcomes of the classification, but also with respect to the promotion of the skills of the model in being flexible to different categories of patients.
The results of the comparative analysis indicate that hybrid models, and the Inception + ResNet in particular, perform better under all conditions of testing, and they are more precise and steady than the CNNs do. The strength of the proposed framework is also supported by the correlation analysis because hybrid models and the ground-truth results are highly related. This shows the need to integrate multi-dimensional data and hybrid architectures as a solution to mitigating the demerits of the individual models that led to a more reliable diagnostic system.
The alternative essential contribution of the invention is the explainability that has been added through Grad-CAM visualizations. Transparency necessitates the creation of heat maps to highlight the nature of data that results in the decision made regarding the classification change, which is a feature of transparency. The given framework suggests having medical practitioners who can examine and evaluate the reasoning of the predictions in contrast to the traditional AI systems of the black-box kind. Such explainability can be helpful in making someone trust AI-related medical equipment and allowing the practitioners to treat the system as a decision-support tool and not as a diagnostic one.
The strategy of deployment makes the invention more applicable. The system provides intermediate scalability between the cloud system and the hospital information systems and lightweight mobile or wearable applications that is in reaction to the demand of accessible and real-time diagnostics. This will come in handy especially in the rural and low resources districts where there is no special medical knowledge. Early interventions may be achieved as the forecasting is provided virtually real time which may lower the morbidity and mortality rate connected with heart disease.
In a bigger picture, the invention also shows how AI-based multi-modal healthcare systems have a potential to revolutionize the process of disease diagnosis in not only the cardiovascular area but also any other area where it will be applied. The data fusion, hybrid architecture, and explainable AI methodological background can be applied beyond the oncology sphere, and also in neurology, or metabolic disorders, and it suggests that the invention is not only highly effective, but it can also be applied to broader healthcare issues.
In short the discussion establishes that the proposed invention will solve the immense issues of the available solutions because it proposes:
• Wholesome person integration of clinical, lifestyle, and genetic data.
• Improved accuracy and generalization using hybrid CNN architecture.
• Grad-CAM explainable and transparency and interpretability.
• Supportiveness on a range of platforms.
• Broadening to the broader healthcare uses.
The invention is one of the most important milestones towards precision medicine, and the gap between big data analytics and effective clinical decision-making due to this technical novelty and practical application.

I. Conclusion
The invention proposes a novel, AI -based, multi-dimensional data fusion structure of heart disease diagnosis whereby clinical, lifestyle, and genetic data can be synthesized into a single diagnostic pipeline. The given system can be employed in order to offer a more universal and accurate approach to evaluating cardiovascular risk since unlike the traditional mode of operation the systematically represented method of cardiovascular risk the interaction of multiple health determinants.
The use of hybrid deep learning models: ResNet, MobileNet, Inception, VGG-16, etc. ensure that different features are learned at different levels and scales. Not only can the predictive performance of this hybrid design be improved but generalization of the model on a diversity of datasets, as well as in real world conditions is also enhanced. The attention processes included in the framework make the process of diagnosing even easier as it focuses on the salient features and eliminates the noise.
The invention has gone through a lot of performance tests and has demonstrated that hybrid models always work better than standalone CNN architectures regardless of the type of conditions. Certain results suggest the flexibility and robustness of the system, particularly during the existence of noisy, inconsistent or incomplete sources of data. The correlation analysis also shows that the hybrid models are quite and on a consistent basis in line with ground-truth results, which increases the consistency as regards to reliability in clinical practice.
Among the main advantages of the invention, it is possible to state the ability to explain the invention with the help of Grad-Cam visualizations providing heatmaps to learn which aspects are the most important and which ones are used by the system to make a decision. Such interpretability is one means to address an old issue that AI models are generally black-boxes and the fact that medical practitioners can understand and justify the predictions. Consequently, the system will result in the development of greater trust and integration into clinical workflows will become less difficult.
It is also important in the versatility of deployment of the invention. The framework can be scaled and accessed via supporting cloud-based applications, hospital information and lightweight mobile applications. This flexibility is particularly needed in the expansion of diagnostic might to the rural and resource constrained areas where there is generally a lack of professional healthcare expertise. The invention can assist greatly in reducing the treatment time and growing patient outcomes directly because of the real-time predictions and portability.
In conclusion, the specified invention is a multi-dimensional, elaborate, and scalable method of the problem of heart diseases diagnostics. It also goes a step further and incorporates multi-dimensional data, hybrid deep learning and interpretability capabilities into a single system. Besides cardiovascular medical care, the methodological underpinnings of this invention, data fusion, model hybridization, and explainable AI, have a high probability of bringing other medical fields, and this is why it will be an excellent addition to the advancement of precision medicine and AI-based healthcare innovation.
, C , C , Claims:Claim 1 (Independent Claim):
A heart disease diagnosis computer-implemented system, which includes:
o a data acquisition component activated to accept multi-dimensional health information such as clinical, lifestyle and genetic indicators.
o a preprocessing component of normalizing, encoding, and preparing the data received.
o a hybrid deep learning architecture that consists of convolutional neural network (CNN) designs such as ResNet, MobileNet, Inception and VGG-16 designed in a pyramid structure.
o a fusion layer that is set up to combine isolated features of the CNN structures, as the fusion layer contains attention systems and squeeze-and-excitation blocks to prioritize significant features.
o Classification layer: a global average pooling, fully connected layers, and a binary classification Softmax layer classification of whether or not the patient has a heart disease risk.
o an explainability module making use of gradient-weighted class activation mapping (Grad-CAM) to create interpretive visualizations of the classification results.
Claim 2: The system under consideration, which includes the clinical parameters of blood pressure, cholesterol levels, electrocardiogram (ECG) results and echocardiography measurements.
Claim 3: The Claim 1 system where the lifestyle indicators include diet, physical activity, smoking status, alcohol consumption, sleep quality and stress levels.
Claim 4: The Claim 1 system according to which the genetic data consists of variations of DNA, family history, and genomic biomarkers linked to the risk of cardiovascular diseases.
Claim 5: The Claim 1 system, in which the preprocessing module entails data augmentation methods that involve rotation, flipping, contrast adjustment, and brightness variation in enhancing generalization of the deep learning model.
Claim 6: A system of Claim 1, which is an attention mechanism consisting of squeeze-and-excitation (SE) blocks, which weight feature maps by the importance of their diagnostic value.
Claim 7: The Claim 1 system, where the explainability module compiles Grad-CAM heatmaps to provide a graphical representation of the important input features that affect the classification decision in order to promote greater clinical understandability.
Claim 8: The system of Claim 1, which also includes a deployment module that will be programmed to be integrated with cloud platforms and hospital information systems as well as mobile apps to support real-time predictions in both clinical and non-clinical settings.
Claim 9: The system of Claim 8, the mobile one being scaled to low-resource settings and providing diagnostic predictions in less than 200 milliseconds.
Claim 10: The Claim 1 system according to which the hybrid CNN framework can be extrapolated to the other medical fields such as oncology, neurology, and diagnostics of metabolic diseases.